[HTML][HTML] SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
RP Czekay, CE Higgins, HB Aydin, R Samarakoon… - Cells, 2024 - mdpi.com
A heterogenous population of inflammatory elements, other immune and nonimmune cells
and cancer-associated fibroblasts (CAFs) are evident in solid malignancies where they …
and cancer-associated fibroblasts (CAFs) are evident in solid malignancies where they …
Emerging Targeted Therapies and Strategies to Overcome Resistance in Biliary Tract Cancers
T Demir, C Moloney, D Mahalingam - Critical Reviews in Oncology …, 2024 - Elsevier
In the last decade, targeted therapies have shown rapid advancement in biliary tract cancer
(BTC). Today, many targeted agents are available and under investigation for patients with …
(BTC). Today, many targeted agents are available and under investigation for patients with …
[HTML][HTML] Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune Score (mGRIm-s) as a clinico …
Y Ma, Y Pan, Y Li, H Guan, G Dai - Journal of Cancer Research and …, 2024 - Springer
Background The emergence of immune checkpoint inhibitors (ICIs) has enhanced survival
outcomes for certain patients with advanced biliary tract carcinoma (BTC). Pinpointing those …
outcomes for certain patients with advanced biliary tract carcinoma (BTC). Pinpointing those …
[HTML][HTML] Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma
Q Liu, Y Chen, Y Hu, J Yang - Cancer Treatment and Research …, 2023 - Elsevier
Cholangiocarcinoma (CCA) is a common and highly malignant form of cancer that has
shown high rates of morbidity and mortality in recent years. The prognosis for …
shown high rates of morbidity and mortality in recent years. The prognosis for …